Chikungunya vaccine, also tested in Brazil, has positive results with patients in the US

2023-06-13 17:04:26

The study whose results were released this Tuesday (13) was carried out with patients in the United States, where the virus is not endemic. However, Valneva – the Franco-Austrian pharmaceutical company responsible for the vaccine – is also testing the vaccine on teenagers in Brazil, a country where chikungunya is endemic. The new results could be decisive for the future of the drug.
#Chikungunya #vaccine #tested #Brazil #positive #results #patients